[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[metoprolol] |
2.56 |
|
5.0 |
|
HPLC |
Jong-Seong Kang 2002 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[metoprolol] |
2.39 |
|
4.0 |
|
UV |
Jong-Seong Kang 2002 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[metoprolol] |
2.37 |
1.28 |
4.0 |
|
CE |
Jong-Seong Kang 2002 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Noradrenaline] |
2.64 |
|
|
|
NMR |
Seunho Jung 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] |
2.98 |
1.60 |
3.3 |
20.0 |
HPLC-method |
Martin M.F. Choi 2001 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] |
3.55 |
2.82 |
4.4 |
20.0 |
HPLC-method |
Martin M.F. Choi 2001 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] |
3.70 |
2.98 |
5.3 |
20.0 |
HPLC-method |
Martin M.F. Choi 2001 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] |
2.96 |
2.08 |
6.0 |
20.0 |
HPLC-method |
Martin M.F. Choi 2001 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] |
2.68 |
1.30 |
6.5 |
20.0 |
HPLC-method |
Martin M.F. Choi 2001 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] |
2.52 |
1.43 |
3.3 |
20.0 |
Fluorescence spectroscopy |
Martin M.F. Choi 2001 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] |
2.62 |
1.23 |
4.4 |
20.0 |
Fluorescence spectroscopy |
Martin M.F. Choi 2001 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] |
2.88 |
1.67 |
5.3 |
20.0 |
Fluorescence spectroscopy |
Martin M.F. Choi 2001 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] |
3.30 |
1.46 |
6.0 |
20.0 |
Fluorescence spectroscopy |
Martin M.F. Choi 2001 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] |
3.31 |
2.14 |
6.5 |
20.0 |
Fluorescence spectroscopy |
Martin M.F. Choi 2001 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[procaine hydrochloride] |
2.96 |
1.76 |
7.5 |
20.0 |
Fluorescence spectroscopy |
Martin M.F. Choi 2001 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[chlorambucil] |
2.86 |
1.48 |
7.35 |
40.0 |
HPLC-method |
Thorsteinn Loftsson 1998 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[indomethacin] |
1.85 |
1.00 |
9.8 |
40.0 |
HPLC-method |
Thorsteinn Loftsson 1998 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[diazepam] |
1.00 |
|
2.0 |
30.5 |
HPLC-method |
Thorsteinn Loftsson 1998 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–D-PheNH2] |
1.66 |
|
3.6 |
20.0 |
Capillary electrophoresis |
Gerhard K.E. Scriba 1999 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–D-PheNH2] |
1.59 |
|
5.25 |
20.0 |
Capillary electrophoresis |
Gerhard K.E. Scriba 1999 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–L-PheNH2] |
1.84 |
|
3.6 |
20.0 |
Capillary electrophoresis |
Gerhard K.E. Scriba 1999 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–L-PheNH2] |
1.43 |
|
5.25 |
20.0 |
Capillary electrophoresis |
Gerhard K.E. Scriba 1999 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-D-Asp–D-PheNH2] |
1.75 |
|
3.6 |
20.0 |
Capillary electrophoresis |
Gerhard K.E. Scriba 1999 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-D-Asp–D-PheNH2] |
1.35 |
|
5.25 |
20.0 |
Capillary electrophoresis |
Gerhard K.E. Scriba 1999 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[butyric acid] |
0.18 |
-0.10 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[isobutyric acid] |
0.49 |
|
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[valeric acid] |
1.47 |
0.43 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[isovaleric acid] |
1.28 |
0.23 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[lactic acid] |
2.51 |
1.50 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[succinic acid] |
2.43 |
1.40 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[cadaverine] |
1.14 |
0.04 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[putrescine] |
0.94 |
0.08 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[pyridine ] |
0.98 |
-0.40 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[pyridine ] |
1.59 |
0.56 |
4.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[3-methyl-pyridine] |
1.01 |
-0.15 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[3-methyl-pyridine] |
1.44 |
0.15 |
4.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[diphenylamine] |
1.92 |
0.76 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[hydrogen sulfide] |
0.22 |
-0.42 |
|
22.0 |
HS-GCMS |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[methanethiol] |
-0.46 |
-1.15 |
|
22.0 |
HS-GCMS |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[dimethyl sulfide] |
0.20 |
-0.82 |
|
22.0 |
HS-GCMS |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[phenyl acetate] |
1.82 |
0.73 |
8.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[phenyl acetate] |
1.39 |
0.92 |
4.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[m-cresol] |
1.55 |
0.45 |
8.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[m-cresol] |
0.81 |
0.38 |
4.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[phenol ] |
1.47 |
-0.05 |
8.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[phenol ] |
1.36 |
0.32 |
4.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[indole] |
1.85 |
0.08 |
8.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[indole] |
1.85 |
1.25 |
4.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[skatole] |
1.86 |
0.63 |
8.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[skatole] |
1.94 |
1.39 |
4.5 |
22.0 |
affinity capillary electrophoresis |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[dodecanol] |
1.40 |
0.48 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[tatradecanol] |
1.55 |
0.40 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[ammonia] |
0.36 |
-0.10 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[methylamine] |
0.68 |
|
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[L-Ala-L-Phe] |
1.98 |
|
|
|
Capillary electrophoresis |
Bezhan Chankvetadze 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[D-Ala-D-Phe] |
2.02 |
|
|
|
Capillary electrophoresis |
Bezhan Chankvetadze 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[L-Phe-L-Phe] |
2.14 |
|
|
|
Capillary electrophoresis |
Bezhan Chankvetadze 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[D-Phe-D-Phe] |
2.19 |
|
|
|
Capillary electrophoresis |
Bezhan Chankvetadze 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[ketoconazole] |
4.16 |
2.54 |
6.0 |
25.0 |
UV-vis spectroscopy |
Joanna Taraszewska 2005 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[ketoconazole] |
4.42 |
3.15 |
5.0 |
25.0 |
UV-vis spectroscopy |
Joanna Taraszewska 2005 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Safranine T] |
2.78 |
|
7.2 |
20.0 |
Fluorescence spectroscopy |
Shaomin Shuang 2005 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[doxazosin enantiomer(2)] |
2.81 |
1.74 |
|
|
HPLC |
Anthony F. Fell 1998 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[dimetindene maleate] |
2.08 |
1.00 |
3.0 |
25.0 |
Capillary electrophoresis |
Yvette Michotte 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](2).[dimetindene maleate] |
2.23 |
1.00 |
3.0 |
25.0 |
Capillary electrophoresis |
Yvette Michotte 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[carbinoxamine maleate] |
2.26 |
1.18 |
3.0 |
25.0 |
Capillary electrophoresis |
Yvette Michotte 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](2).[carbinoxamine maleate] |
2.32 |
1.18 |
3.0 |
25.0 |
Capillary electrophoresis |
Yvette Michotte 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[homatropine hydrobromide] |
1.54 |
1.28 |
3.0 |
25.0 |
Capillary electrophoresis |
Yvette Michotte 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](2).[homatropine hydrobromide] |
1.68 |
1.30 |
3.0 |
25.0 |
Capillary electrophoresis |
Yvette Michotte 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[orciprenaline sulfate] |
2.01 |
1.34 |
3.0 |
25.0 |
Capillary electrophoresis |
Yvette Michotte 2004 |
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](2).[orciprenaline sulfate] |
2.05 |
1.32 |
3.0 |
25.0 |
Capillary electrophoresis |
Yvette Michotte 2004 |